Privacy Policy | Anvisa publishes a generic registry to fight infections

The National Sanitary Surveillance Agency (Anvisa) has published the generic dossier levofloxacin hemihydrate as a solution for injection for infusion. The remedy is indicated to treat bacterial infections, such as respiratory tract infections, skin infections, urinary tract infections and bones.

"With the registration of the generic drug, Anvisa guarantees the product quality, effective and

Another benefit of registration, according to the release, is the reduction in the cost of treatment, because the drugs the generic drugs must enter the market with a value at least 35% lower than that of the reference medicine